Following the approval criteria from Health Canada for genetic approvals, CCG will facilitate the connections they need with experienced master growers who are able to provide exclusive genetics for the medical market. Genetics play the most significant role in producing new and improved cultivars, terpenes, yields, density, potency and cannabinoids that are highly sought after by medical patients and consumers. Starting with the highest quality genetics will also provide the public with a more informed choice in the process of choosing the best medical cannabis for their specific ailment or medical condition. Our connections to high-end genetic sourcing will provide growers with the opportunity to care for the best of the best strains.
Ultimately, it will better the cultivation process by providing micro growers with a large variation of genetics and profiles that nobody else will have in the industry. It allows growers to focus less on the start-up process and the research process, and more on caring and tending for the cannabis plant so that it can flower into the best possible end product. It also allows the team to track and record profiles for each cultivar based on cannabinoid and terpene content such as THC and CBD so that we can provide feedback for the development of future strains.